Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms

Autor: Andrea Duminuco, Joshua Au Yeung, Raj Vaghela, Sukhraj Virdee, Claire Woodley, Susan Asirvatham, Natalia Curto‐Garcia, Priya Sriskandarajah, Jennifer O'Sullivan, Hugues deLavallade, Deepti Radia, Shahram Kordasti, Giuseppe Palumbo, Claire Harrison, Patrick Harrington

Publikováno v: HemaSphere, Vol 8, Iss 8, Pp n/a-n/a (2024)

Externí odkaz: https://doaj.org/article/ad9804a8b83240f5a4c1bfbcfdaff867

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)

Autor: Jumoke Okikiolu, Claire Woodley, Llywelyn Cadman-Davies, Jennifer O'Sullivan, Deepti Radia, Natalia Curto Garcia, Patrick Harrington, Shahram Kordasti, Susan Asirvatham, Priya Sriskandarajah, Jamie Saunders, Chandan Saha, Irene Sanchez, Hugues deLavallade, Donal P McLornan, Claire N Harrison

Publikováno v: Leukemia Research Reports, Vol 19, Iss , Pp 100360- (2023)

Despite widespread use of Pegylated forms of Inteferon in the management of Myeloproliferative Neoplasms (MPN), most clinicians have experience predominantly with peginterferon alfa-2a (Pegasys). Third generation pegylated IFNα, ropeginterferon alfa

Externí odkaz: https://doaj.org/article/c09dc41d2ca24fb0853b44f1560e6c69

Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center

Autor: Alesia Khan, Claire Woodley, Deepti Radia, George N. Mikhaeel, Jessica Brady, Natalia Curto Garcia, Patrick Harrington, Jennifer O’Sullivan, Shahram Kordasti, Yvonne Francis, Susan Asirvatham, Sahra Ali, Priya Sriskandarajah, Jamie Saunders, Hugues de Lavallade, Donal P. McLornan, Claire N. Harrison

Publikováno v: HemaSphere, Vol 5, Iss 7, p e611 (2021)

Externí odkaz: https://doaj.org/article/9bf13ba33ca94e558c21db22cc1d45ba

Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype

Autor: Patrick Harrington, Richard Dillon, Deepti Radia, Donal McLornan, Claire Woodley, Susan Asirvatham, Kavita Raj, Natalia Curto‐Garcia, Jamie Saunders, Shahram Kordasti, Claire Harrison, Hugues de Lavallade

Publikováno v: Harrington, P, Dillon, R, Radia, D, McLornan, D, Woodley, C, Asirvatham, S, Raj, K, Curto-Garcia, N, Saunders, J, Kordasti, S, Harrison, C & de Lavallade, H 2022, ' Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype ', British Journal of Haematology, vol. 198, no. 6, pp. 1011-1015 . https://doi.org/10.1111/bjh.18302

The search for novel targets in chronic myeloid leukaemia (CML) is ongoing, to improve treatment efficacy in refractory disease and increase eligibility for tyrosine kinase inhibitor (TKI) discontinuation. Increased frequency of Tregs and effector Tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b7ff8a9156123ac76e5871c64fabeb
https://doi.org/10.1111/bjh.18302

Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders

Autor: Patrick Harrington, Ashwini Kurshan, Marc Delord, Thomas Lechmere, Amna Sheikh, Jamie Saunders, Chandan Saha, Richard Dillon, Claire Woodley, Susan Asirvatham, Natalia Curto-Garcia, Jennifer O’ Sullivan, Shahram Kordasti, Deepti Radia, Donal McLornan, Michael H. Malim, Claire Harrison, Katie J. Doores, Hugues de Lavallade

Publikováno v: Blood advances.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501a7629f585bd28db2a4ab700e4b08d
https://pubmed.ncbi.nlm.nih.gov/36083126